Clinicopathological Characteristics of Gastric Hepatoid Adenocarcinoma.
10.7704/kjhugr.2017.17.2.88
- Author:
Jung Bin YOON
1
;
Gwang Ha KIM
;
Do Youn PARK
;
Young Geum KIM
;
Sung Ik PYEON
;
Bong Eun LEE
;
Geun Am SONG
Author Information
1. Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. doc0224@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Adenocarcinoma;
Chemotherapy;
Endoscopy;
Hepatocelluar carcinoma;
Stomach
- MeSH:
Adenocarcinoma*;
Carcinoma, Hepatocellular;
Chemotherapy, Adjuvant;
Diagnosis;
Drug Therapy;
Endoscopy;
Humans;
Liver;
Lymph Nodes;
Male;
Medical Records;
Neoplasm Metastasis;
Prognosis;
Retrospective Studies;
Stomach;
Stomach Neoplasms
- From:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
2017;17(2):88-93
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Gastric hepatoid adenocarcinoma (GHA), a rare type of primary gastric cancer, is characterized by a histology resembling hepatocellular carcinoma. Previous case studies reported that patients with GHA have a poor prognosis due to early lymph node or liver metastasis, but information concerning GHA is still limited. Therefore, we aimed to evaluate the clinicopathological features of GHA. MATERIALS AND METHODS: We reviewed the medical records of 9 patients who were diagnosed as having GHA between January 2011 and December 2016. The clinicopathological characteristics of these patients were retrospectively analyzed. RESULTS: The median age of the patients at diagnosis was 68.9 years. Seven of the 9 patients were male. Serum AFP levels were elevated in 3 of 4 patients. All the tumors were >4 cm (range, 4~12 cm), and 7 tumors were located at the lower third of the stomach. Five tumors were classified as Borrmann's type 3, with a purple, berry-like surface. Of the 6 patients without distant metastasis, 5 received curative-intent surgery and 3 received adjuvant chemotherapy. Three patients with distant metastasis received either palliative operation and/or chemotherapy. Their median survival time was 11.8 months (range, 1~36 months). Two patients with elevated serum CEA levels had poor outcomes. CONCLUSIONS: GHA is a rare subtype of gastric cancer that is prone to liver metastasis. All GHAs are advanced gastric cancer with a purple, berry-like surface at diagnosis. Although the prognosis of advanced-stage GHA is poor, active multimodality treatment might provide some benefit.
